Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Longs should put in a sell order for their shares to prevent them being loaned out for shorting. Set a limit order at $40 or so just to tie them up and thwart them from using your shares to hurt you.
Not sure where I saw the post, but it said MNKD was going to supply spirometers to doctors for free to test lung function. Anyone have a link to this story?
Good point- watch the market cap growth, not share price growth.
I got TOS'd for being "off topic". I was trying to point out the repeated posts of one who had nothing substantial to say but said it repeatedly. We all know who it is, yet the administrator had no problem with him as a moderator who also can delete our posts yet post his own nonsense ("moderators have a right to post their opinions too"). Yes, but saying the same thing 20 times and is no way impartial, which is needed for that role? Very bizarre. This board is broken.
Phaeton, I did what you encouraged me to do.
Phaeton, I agree with you wholeheartedly.
This board desperately needs a moderator. Its devolving into a Yahoo-type board. Lets get back to talking about MNKD and just MNKD-related news.
Please remember that my comments were in relation to the spate of comments the past few days about "insider buying". The GuruFocus article referring to the filings was the last straw.
http://www.gurufocus.com/forum/read.php?2,268722,268779#msg-268779
I have no issue with insiders selling all or part of their shares. My issue was with how the filings were being couched as insider buying. Many received free shares with the rest receiving them at deep discounts to the market price, so using the term "buying" is the wrong phrase. "Insider accumulation" would be more appropriate. One is a transaction, the other more of a gift.
My point is this that some posters are making this out to be like they bought at market prices, but its not. they got shares cheap or free and many sold all or a chunk of them. I interpret some of these comments on these acquisitions as wishful thinking. Just trying to keep it real.
Great article on a new protein that reduces glucose levels in diabetic mice. Fascinating news!
http://www.dailymail.co.uk/health/article-2695153/Protein-discovery-reverse-damage-diabetes-Breakthrough-lead-cheap-drug-halt-disease.html
Yes, that article bugged me and all the disinformation- on both sides now. I just want an honest discussion of the facts, but some people insist on muddying the waters for their own reasons. For those who do their own DD, it only hurts their credibility.
In from 2.31 and will ride it until Al sells.
IN AL WE TRUST.
Insiders bought these shares thru options and many sold from half to all of them. Here are a few examples for those who want to take the time to examine the filings:
Thomson acquired 30,000 shares @ $1.69 and sold all at $9.41
Pfeffer acquired 229K shares @ $0 and sold them all at $10
Dianne the "disposal queen" Palumbo sold hers too.
Juergen acquired 247K @ $0 and sold 120k @ $10.
Recent insider activity is not what some people are trying to make out. Lets keep it honest.
As I remember it was just under $1B in cryogenic storage.
Stock options that's all. They didn't buy on the open market.
The first 4 filers acquired then disposed of most or all of them. I would not get all that wound up over it.
WTF, a new article comes out today and it tanks 33% right at the end of the day? Smells like a pump and dump.
Think about it conversely:
If the BUYER is convinced of the potential of Technosphere and/or Afrezza, and is confident he can market the hell out of this, $40 is cheap when thinking about it from a long term perspective.
Much depends on the buyer's state of mind and how he is approaching this opportunity.
Someone needs to ask Al is he still buys green bananas...
The author never referred to the extensive marketing studies MNKD did that showed doctors would overwhelmingly prescribe Afrezza if approved. That's what makes this a hack piece.
If it is a partnership announcement, the partner may have a say in when the news is announced. I think you are right as far as being before the bell on a Monday since that would have the biggest effect, but I don't see it happening until later this month. I'll say Monday, the 28th. That's my guess.
nice little breakout today.
Wait, iHub? i thought I was on the Yahoo board after that rant. Keep it civil.
Sanofi bought that Frankfurt plant in June 2009, but bought $3m worth of bulk insulin from Pfizer.
The point is, Pfizer thought enough of MNKD to accept their shares as payment in this deal. Why would they accept them if they thought they may be worthless someday? That speaks volumes about Pfizer's attitude toward MNKD.
That was me too. Getting the word out on what I believe is a significant clue as to potential partner.
There is an existing agreement between MNKD and Pfizer to buy the latter's insulin manufacturing facility in Frankfurt. Pfizer can accept up to $30m in shares of MNKD to buy it too.
Someone tell me that Pfizer doesn't believe in Afrezza now.
http://www.news.mannkindcorp.com/phoenix.zhtml?c=147953&p=irol-newsArticle&ID=1263905&highlight=
Since this subject is bound to come up in Afrezza's future, I looked into the statistical risk of lung cancer and came across this. There may be more current studies out there but this is helpful to understand the risk of lung cancer for smokers and non-smokers.
In a 2006 European study, the risk of developing lung cancer was:
0.2% for men who never smoked (0.4% for women)
5.5% for male former smokers (2.6% in women)
15.9% for current male smokers (9.5% for women)
24.4% for male “heavy smokers” defined as smoking more than 5 cigarettes per day (18.5% for women)
http://lungcancer.about.com/od/Lung-Cancer-And-Smoking/f/Smokers-Lung-Cancer.htm
It would be interesting to know what the breakdown was in the placebo group where there were no cancer cases. If they had say all men who never smoked, they would have a much lower statistical chance of it showing up in the study. Conversely if the group of Afrezza users had more smokers, it would increase the statistical chance.
So any risk of lung cancer from Afrezza would have be be above the median average for the person: male/female, smoker/non-smoker for the statistic to be meaningful.
No, President Hakan Edstrom. After Charles mentioned he'd followed MNKD for 10 years, he goes on to call Hakan "Hakeem". He knows the company well...
What happened here? Down 23% today. Selling to buy more MNKD?
Its the end of the quarter, so sometimes they adjust their holdings at that time. It may be because of some being added to an index or being dropped for example. Then there is end of month "window dressing" where they sell off dogs and buy popular ones to make the monthly holdings look good. Often buying back the ones they just sold and selling off the ones they bought.
I should have gone further and called it a bear raid. They drove it down and grabbed up all the stops and took it right back up. Probably more likely.
It was just classic "sell the news". No one seems to be applying the old adage.
This is for all the shorts, and especially for AF.
How Ya Like Me Now?
You sound way too emotionally involved here. I'd suggest just cutting them a check for a donation, but don't use client's funds for investing in it. As well intentioned as you are, leave emotion out of investing and don't mix the two.
A little disappointed that the accuracy rate of the assay urine test is just 88% (as stated in the CC).
Anyone know what the rate is for the blood test?
yes, a long one building too. A good reason to be optimistic here.
You're just focused on the higher share price and not the tiny float. A small float will eliminate just as many institutional investors as a low share price will.
RS makes no sense at 42m shares OS. You get a higher share price, but it kills daily volume which keeps investors away too.
I have not come across a projected date but probably closer to three years for Quantum.
I found that there are 5 companies right now with plans to build refineries in ND with similar production capacities of 20,000 bbls/day for diesel: MDU/Calumet, Quantum, MHA Nation, Dakota Oil Processing, and American Energy holdings.
The current demand is said to be 55,000 bbls/day with demand expected to be 75,000 bbls/day by 2025. Looks like a glut of diesel refinery capacity isn't too far off.
Someone explain how their won't be a glut if Dakota Prairie Refinery( Calumet) is building the same capacity refinery (20,000 bbls/day) and the same refined products as Quantum's Fairview?